Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

A Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea
A Randomized, Double-Blinded, Active-Controlled Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea
Status: Enrolling
Updated:  7/21/2015
Clinical Research Facility
mi
from
Charleston, SC
A Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea
A Randomized, Double-Blinded, Active-Controlled Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea
Status: Enrolling
Updated: 7/21/2015
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
A Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea
A Randomized, Double-Blinded, Active-Controlled Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea
Status: Enrolling
Updated:  7/21/2015
Clinical Research Facility
mi
from
Chattanooga, TN
A Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea
A Randomized, Double-Blinded, Active-Controlled Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea
Status: Enrolling
Updated: 7/21/2015
Clinical Research Facility
mi
from
Chattanooga, TN
Click here to add this to my saved trials
A Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea
A Randomized, Double-Blinded, Active-Controlled Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea
Status: Enrolling
Updated:  7/21/2015
Clinical Research Facility
mi
from
Jackson, TN
A Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea
A Randomized, Double-Blinded, Active-Controlled Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea
Status: Enrolling
Updated: 7/21/2015
Clinical Research Facility
mi
from
Jackson, TN
Click here to add this to my saved trials
A Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea
A Randomized, Double-Blinded, Active-Controlled Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea
Status: Enrolling
Updated:  7/21/2015
Clinical Research Facility
mi
from
Dallas, TX
A Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea
A Randomized, Double-Blinded, Active-Controlled Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea
Status: Enrolling
Updated: 7/21/2015
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea
A Randomized, Double-Blinded, Active-Controlled Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea
Status: Enrolling
Updated:  7/21/2015
Clinical Research Facility
mi
from
El Paso, TX
A Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea
A Randomized, Double-Blinded, Active-Controlled Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea
Status: Enrolling
Updated: 7/21/2015
Clinical Research Facility
mi
from
El Paso, TX
Click here to add this to my saved trials
A Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea
A Randomized, Double-Blinded, Active-Controlled Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea
Status: Enrolling
Updated:  7/21/2015
Clinical Research Facility
mi
from
Fort Worth, TX
A Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea
A Randomized, Double-Blinded, Active-Controlled Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea
Status: Enrolling
Updated: 7/21/2015
Clinical Research Facility
mi
from
Fort Worth, TX
Click here to add this to my saved trials
A Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea
A Randomized, Double-Blinded, Active-Controlled Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea
Status: Enrolling
Updated:  7/21/2015
Clinical Research Facility
mi
from
Galveston, TX
A Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea
A Randomized, Double-Blinded, Active-Controlled Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea
Status: Enrolling
Updated: 7/21/2015
Clinical Research Facility
mi
from
Galveston, TX
Click here to add this to my saved trials
A Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea
A Randomized, Double-Blinded, Active-Controlled Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea
Status: Enrolling
Updated:  7/21/2015
Clinical Research Facility
mi
from
Houston, TX
A Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea
A Randomized, Double-Blinded, Active-Controlled Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea
Status: Enrolling
Updated: 7/21/2015
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
A Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea
A Randomized, Double-Blinded, Active-Controlled Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea
Status: Enrolling
Updated:  7/21/2015
Clinical Research Facility
mi
from
Lynchburg, VA
A Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea
A Randomized, Double-Blinded, Active-Controlled Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea
Status: Enrolling
Updated: 7/21/2015
Clinical Research Facility
mi
from
Lynchburg, VA
Click here to add this to my saved trials
A Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea
A Randomized, Double-Blinded, Active-Controlled Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea
Status: Enrolling
Updated:  7/21/2015
Clinical Research Facility
mi
from
Virginia Beach, VA
A Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea
A Randomized, Double-Blinded, Active-Controlled Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea
Status: Enrolling
Updated: 7/21/2015
Clinical Research Facility
mi
from
Virginia Beach, VA
Click here to add this to my saved trials
A Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea
A Randomized, Double-Blinded, Active-Controlled Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea
Status: Enrolling
Updated:  7/21/2015
Clinical Research Facility
mi
from
Madison, WI
A Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea
A Randomized, Double-Blinded, Active-Controlled Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea
Status: Enrolling
Updated: 7/21/2015
Clinical Research Facility
mi
from
Madison, WI
Click here to add this to my saved trials
University of Texas H.S.C. San Antonio Pioglitazone in Non-Alcoholic Steatohepatitis Trial (UTHSCSA NASH Trial)
Long-term Role of Pioglitazone in Non-Alcoholic Fatty Liver Disease (NAFLD) in Type 2 Diabetes Mellitus (T2DM).
Status: Enrolling
Updated:  7/24/2015
Bartter Research Unit, Audie L Murphy VA Hospital
mi
from
San Antonio, TX
University of Texas H.S.C. San Antonio Pioglitazone in Non-Alcoholic Steatohepatitis Trial (UTHSCSA NASH Trial)
Long-term Role of Pioglitazone in Non-Alcoholic Fatty Liver Disease (NAFLD) in Type 2 Diabetes Mellitus (T2DM).
Status: Enrolling
Updated: 7/24/2015
Bartter Research Unit, Audie L Murphy VA Hospital
mi
from
San Antonio, TX
Click here to add this to my saved trials
Prediction of Severity of Liver Disease by a 13C Octanoate Breath Test (OBT)
Prediction of Severity of Liver Disease in Patients With Suspected Nonalcoholic Fatty Liver Disease (NAFLD) by 13C Octanoate Breath Test (OBT)
Status: Enrolling
Updated:  7/27/2015
Baylor College of Medicine
mi
from
Houston, TX
Prediction of Severity of Liver Disease by a 13C Octanoate Breath Test (OBT)
Prediction of Severity of Liver Disease in Patients With Suspected Nonalcoholic Fatty Liver Disease (NAFLD) by 13C Octanoate Breath Test (OBT)
Status: Enrolling
Updated: 7/27/2015
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Prediction of Severity of Liver Disease by a 13C Octanoate Breath Test (OBT)
Prediction of Severity of Liver Disease in Patients With Suspected Nonalcoholic Fatty Liver Disease (NAFLD) by 13C Octanoate Breath Test (OBT)
Status: Enrolling
Updated:  7/27/2015
Virginia Commonwealth University
mi
from
Richmond, VA
Prediction of Severity of Liver Disease by a 13C Octanoate Breath Test (OBT)
Prediction of Severity of Liver Disease in Patients With Suspected Nonalcoholic Fatty Liver Disease (NAFLD) by 13C Octanoate Breath Test (OBT)
Status: Enrolling
Updated: 7/27/2015
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
Anti-Interleukin-5 (IL-5) Study for Hypereosinophilic Syndrome
A Phase I/II Study of the Effect of Intravenous Anti-IL-5 (Mepolizumab) SB 240563 on the Outcome and Management of Hypereosinophilic Syndromes
Status: Enrolling
Updated:  7/27/2015
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Anti-Interleukin-5 (IL-5) Study for Hypereosinophilic Syndrome
A Phase I/II Study of the Effect of Intravenous Anti-IL-5 (Mepolizumab) SB 240563 on the Outcome and Management of Hypereosinophilic Syndromes
Status: Enrolling
Updated: 7/27/2015
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Treatment of Hypovitaminosis D in Rheumatoid Arthritis
Treatment of Hypovitaminosis D in Rheumatoid Arthritis
Status: Enrolling
Updated:  7/27/2015
University of Wisconsin
mi
from
Madison, WI
Treatment of Hypovitaminosis D in Rheumatoid Arthritis
Treatment of Hypovitaminosis D in Rheumatoid Arthritis
Status: Enrolling
Updated: 7/27/2015
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
Prevalence of Cytomegalovirus, Epstein Barr Virus and Human Herpes 6 Virus in Inflammatory Bowel Disease
Prevalence of Cytomegalovirus, Epstein Barr Virus and Human Herpes 6 Virus DNA in Intestinal Mucosa of Patients With Inflammatory Bowel Disease
Status: Enrolling
Updated:  7/28/2015
Jackson Memorial Hospital
mi
from
Miami, FL
Prevalence of Cytomegalovirus, Epstein Barr Virus and Human Herpes 6 Virus in Inflammatory Bowel Disease
Prevalence of Cytomegalovirus, Epstein Barr Virus and Human Herpes 6 Virus DNA in Intestinal Mucosa of Patients With Inflammatory Bowel Disease
Status: Enrolling
Updated: 7/28/2015
Jackson Memorial Hospital
mi
from
Miami, FL
Click here to add this to my saved trials
FMRI of Stress and Addictive Disorders
Functional Magnetic Resonance Imaging of Stress and Addictive Disorders
Status: Enrolling
Updated:  7/28/2015
Yale Stress Center
mi
from
New Haven, CT
FMRI of Stress and Addictive Disorders
Functional Magnetic Resonance Imaging of Stress and Addictive Disorders
Status: Enrolling
Updated: 7/28/2015
Yale Stress Center
mi
from
New Haven, CT
Click here to add this to my saved trials
Enteral Glutamine in Reducing Bloodstream Infections in Short Bowel Syndrome Infants
Efficacy of Enteral Glutamine in Reducing Bloodstream Infections in Short Bowel Syndrome Infants
Status: Enrolling
Updated:  7/28/2015
C.S. Mott Children's Hosptial
mi
from
Ann Arbor, MI
Enteral Glutamine in Reducing Bloodstream Infections in Short Bowel Syndrome Infants
Efficacy of Enteral Glutamine in Reducing Bloodstream Infections in Short Bowel Syndrome Infants
Status: Enrolling
Updated: 7/28/2015
C.S. Mott Children's Hosptial
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Enteral Glutamine in Reducing Bloodstream Infections in Short Bowel Syndrome Infants
Efficacy of Enteral Glutamine in Reducing Bloodstream Infections in Short Bowel Syndrome Infants
Status: Enrolling
Updated:  7/28/2015
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Enteral Glutamine in Reducing Bloodstream Infections in Short Bowel Syndrome Infants
Efficacy of Enteral Glutamine in Reducing Bloodstream Infections in Short Bowel Syndrome Infants
Status: Enrolling
Updated: 7/28/2015
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
An Open-Label Pilot Trial to Evaluate the Safety, Tolerability and Efficacy of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
Status: Enrolling
Updated:  7/28/2015
VA Connecticut Healthcare System
mi
from
West Haven, CT
A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
An Open-Label Pilot Trial to Evaluate the Safety, Tolerability and Efficacy of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
Status: Enrolling
Updated: 7/28/2015
VA Connecticut Healthcare System
mi
from
West Haven, CT
Click here to add this to my saved trials
A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
An Open-Label Pilot Trial to Evaluate the Safety, Tolerability and Efficacy of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
Status: Enrolling
Updated:  7/28/2015
Johns Hopkins Sibley Memorial Hospital
mi
from
Washington,
A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
An Open-Label Pilot Trial to Evaluate the Safety, Tolerability and Efficacy of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
Status: Enrolling
Updated: 7/28/2015
Johns Hopkins Sibley Memorial Hospital
mi
from
Washington,
Click here to add this to my saved trials
A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
An Open-Label Pilot Trial to Evaluate the Safety, Tolerability and Efficacy of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
Status: Enrolling
Updated:  7/28/2015
University of Miami
mi
from
Miami, FL
A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
An Open-Label Pilot Trial to Evaluate the Safety, Tolerability and Efficacy of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
Status: Enrolling
Updated: 7/28/2015
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
An Open-Label Pilot Trial to Evaluate the Safety, Tolerability and Efficacy of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
Status: Enrolling
Updated:  7/28/2015
University of Mississippi Medical Center
mi
from
Jackson, MS
A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
An Open-Label Pilot Trial to Evaluate the Safety, Tolerability and Efficacy of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
Status: Enrolling
Updated: 7/28/2015
University of Mississippi Medical Center
mi
from
Jackson, MS
Click here to add this to my saved trials
A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
An Open-Label Pilot Trial to Evaluate the Safety, Tolerability and Efficacy of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
Status: Enrolling
Updated:  7/28/2015
Rutgers New Jersey Medical School
mi
from
Newark, NJ
A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
An Open-Label Pilot Trial to Evaluate the Safety, Tolerability and Efficacy of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
Status: Enrolling
Updated: 7/28/2015
Rutgers New Jersey Medical School
mi
from
Newark, NJ
Click here to add this to my saved trials
A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
An Open-Label Pilot Trial to Evaluate the Safety, Tolerability and Efficacy of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
Status: Enrolling
Updated:  7/28/2015
North Shore University Hospital
mi
from
Manhasset, NY
A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
An Open-Label Pilot Trial to Evaluate the Safety, Tolerability and Efficacy of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
Status: Enrolling
Updated: 7/28/2015
North Shore University Hospital
mi
from
Manhasset, NY
Click here to add this to my saved trials
A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
An Open-Label Pilot Trial to Evaluate the Safety, Tolerability and Efficacy of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
Status: Enrolling
Updated:  7/28/2015
New York University Lagone Medical Center
mi
from
NYC, NY
A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
An Open-Label Pilot Trial to Evaluate the Safety, Tolerability and Efficacy of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
Status: Enrolling
Updated: 7/28/2015
New York University Lagone Medical Center
mi
from
NYC, NY
Click here to add this to my saved trials
A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
An Open-Label Pilot Trial to Evaluate the Safety, Tolerability and Efficacy of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
Status: Enrolling
Updated:  7/28/2015
Albert Einstein Medical Center
mi
from
Philadelphia, PA
A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
An Open-Label Pilot Trial to Evaluate the Safety, Tolerability and Efficacy of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
Status: Enrolling
Updated: 7/28/2015
Albert Einstein Medical Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
An Open-Label Pilot Trial to Evaluate the Safety, Tolerability and Efficacy of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
Status: Enrolling
Updated:  7/28/2015
Univ of Pennsylvania
mi
from
Philadelphia, PA
A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
An Open-Label Pilot Trial to Evaluate the Safety, Tolerability and Efficacy of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
Status: Enrolling
Updated: 7/28/2015
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
An Open-Label Pilot Trial to Evaluate the Safety, Tolerability and Efficacy of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
Status: Enrolling
Updated:  7/28/2015
St. Luke's Health Baylor College of Medicine
mi
from
Houston, TX
A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
An Open-Label Pilot Trial to Evaluate the Safety, Tolerability and Efficacy of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
Status: Enrolling
Updated: 7/28/2015
St. Luke's Health Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
An Open-Label Pilot Trial to Evaluate the Safety, Tolerability and Efficacy of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
Status: Enrolling
Updated:  7/28/2015
University of Texas Health Science Center at Houston
mi
from
Houston, TX
A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
An Open-Label Pilot Trial to Evaluate the Safety, Tolerability and Efficacy of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
Status: Enrolling
Updated: 7/28/2015
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Click here to add this to my saved trials
A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
An Open-Label Pilot Trial to Evaluate the Safety, Tolerability and Efficacy of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
Status: Enrolling
Updated:  7/28/2015
University Of Utah Hospital
mi
from
Salt Lake City, UT
A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
An Open-Label Pilot Trial to Evaluate the Safety, Tolerability and Efficacy of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
Status: Enrolling
Updated: 7/28/2015
University Of Utah Hospital
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
An Open-Label Pilot Trial to Evaluate the Safety, Tolerability and Efficacy of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
Status: Enrolling
Updated:  7/28/2015
Bon Secours Mary Immaculate Hospital
mi
from
Newport News, VA
A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
An Open-Label Pilot Trial to Evaluate the Safety, Tolerability and Efficacy of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
Status: Enrolling
Updated: 7/28/2015
Bon Secours Mary Immaculate Hospital
mi
from
Newport News, VA
Click here to add this to my saved trials
A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
An Open-Label Pilot Trial to Evaluate the Safety, Tolerability and Efficacy of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
Status: Enrolling
Updated:  7/28/2015
Bon Secours St. Mary's Hospital
mi
from
Richmond, VA
A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
An Open-Label Pilot Trial to Evaluate the Safety, Tolerability and Efficacy of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
Status: Enrolling
Updated: 7/28/2015
Bon Secours St. Mary's Hospital
mi
from
Richmond, VA
Click here to add this to my saved trials
A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
An Open-Label Pilot Trial to Evaluate the Safety, Tolerability and Efficacy of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
Status: Enrolling
Updated:  7/28/2015
Mcguire Dvamc
mi
from
Richmond, VA
A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
An Open-Label Pilot Trial to Evaluate the Safety, Tolerability and Efficacy of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
Status: Enrolling
Updated: 7/28/2015
Mcguire Dvamc
mi
from
Richmond, VA
Click here to add this to my saved trials
A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
An Open-Label Pilot Trial to Evaluate the Safety, Tolerability and Efficacy of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
Status: Enrolling
Updated:  7/28/2015
Johns Hopkins Hospital
mi
from
Baltimore, MD
A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
An Open-Label Pilot Trial to Evaluate the Safety, Tolerability and Efficacy of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
Status: Enrolling
Updated: 7/28/2015
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Effectiveness of Lofexidine to Prevent Stress-Related Opiate Relapse During Naltrexone Treatment - 1
Lofexidine: Enhancing Naltrexone Treatment for Opiate Addiction
Status: Enrolling
Updated:  7/28/2015
Yale University, Psychiatry
mi
from
New Haven, CT
Effectiveness of Lofexidine to Prevent Stress-Related Opiate Relapse During Naltrexone Treatment - 1
Lofexidine: Enhancing Naltrexone Treatment for Opiate Addiction
Status: Enrolling
Updated: 7/28/2015
Yale University, Psychiatry
mi
from
New Haven, CT
Click here to add this to my saved trials
Transversus Abdominis Plane (TAP) Versus Local Anesthetic for Lap Appendectomies
A Prospective, Double Blinded, Randomized Comparison of Transversus Abdominis Plane Block Versus Local Anesthetic Infiltration for Laparoscopic Appendectomy in the Pediatric Population
Status: Enrolling
Updated:  7/29/2015
Nationwide Children's Hospital
mi
from
Columbus, OH
Transversus Abdominis Plane (TAP) Versus Local Anesthetic for Lap Appendectomies
A Prospective, Double Blinded, Randomized Comparison of Transversus Abdominis Plane Block Versus Local Anesthetic Infiltration for Laparoscopic Appendectomy in the Pediatric Population
Status: Enrolling
Updated: 7/29/2015
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Ultrasound Stiffness Imaging in Crohn's Disease
Investigating Ultrasound Stiffness Imaging for Predicting Outcomes in Crohn's Disease
Status: Enrolling
Updated:  7/29/2015
University of Michigan Health System
mi
from
Ann Arbor, MI
Ultrasound Stiffness Imaging in Crohn's Disease
Investigating Ultrasound Stiffness Imaging for Predicting Outcomes in Crohn's Disease
Status: Enrolling
Updated: 7/29/2015
University of Michigan Health System
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
An Open-Label Crossover Study to Compare the Relative Bioavailability, Efficacy and Safety of Epanova® and Lovaza® in Men and Women With a History of Pancreatitis
A Randomized, Open-Label Crossover Study to Compare the Relative Bioavailability, Efficacy, and Safety of Epanova® and Lovaza® in Men and Women With a History of Pancreatitis
Status: Enrolling
Updated:  7/29/2015
Clinical Research Facility
mi
from
Addison, IL
An Open-Label Crossover Study to Compare the Relative Bioavailability, Efficacy and Safety of Epanova® and Lovaza® in Men and Women With a History of Pancreatitis
A Randomized, Open-Label Crossover Study to Compare the Relative Bioavailability, Efficacy, and Safety of Epanova® and Lovaza® in Men and Women With a History of Pancreatitis
Status: Enrolling
Updated: 7/29/2015
Clinical Research Facility
mi
from
Addison, IL
Click here to add this to my saved trials
An Open-Label Crossover Study to Compare the Relative Bioavailability, Efficacy and Safety of Epanova® and Lovaza® in Men and Women With a History of Pancreatitis
A Randomized, Open-Label Crossover Study to Compare the Relative Bioavailability, Efficacy, and Safety of Epanova® and Lovaza® in Men and Women With a History of Pancreatitis
Status: Enrolling
Updated:  7/29/2015
Clinical Research Facility
mi
from
Kansas City, KA
An Open-Label Crossover Study to Compare the Relative Bioavailability, Efficacy and Safety of Epanova® and Lovaza® in Men and Women With a History of Pancreatitis
A Randomized, Open-Label Crossover Study to Compare the Relative Bioavailability, Efficacy, and Safety of Epanova® and Lovaza® in Men and Women With a History of Pancreatitis
Status: Enrolling
Updated: 7/29/2015
Clinical Research Facility
mi
from
Kansas City, KA
Click here to add this to my saved trials
An Open-Label Crossover Study to Compare the Relative Bioavailability, Efficacy and Safety of Epanova® and Lovaza® in Men and Women With a History of Pancreatitis
A Randomized, Open-Label Crossover Study to Compare the Relative Bioavailability, Efficacy, and Safety of Epanova® and Lovaza® in Men and Women With a History of Pancreatitis
Status: Enrolling
Updated:  7/29/2015
Clinical Research Facility
mi
from
Cincinnati, OH
An Open-Label Crossover Study to Compare the Relative Bioavailability, Efficacy and Safety of Epanova® and Lovaza® in Men and Women With a History of Pancreatitis
A Randomized, Open-Label Crossover Study to Compare the Relative Bioavailability, Efficacy, and Safety of Epanova® and Lovaza® in Men and Women With a History of Pancreatitis
Status: Enrolling
Updated: 7/29/2015
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
An Open-Label Crossover Study to Compare the Relative Bioavailability, Efficacy and Safety of Epanova® and Lovaza® in Men and Women With a History of Pancreatitis
A Randomized, Open-Label Crossover Study to Compare the Relative Bioavailability, Efficacy, and Safety of Epanova® and Lovaza® in Men and Women With a History of Pancreatitis
Status: Enrolling
Updated:  7/29/2015
Clinical Research Facility
mi
from
Philadelphia, PA
An Open-Label Crossover Study to Compare the Relative Bioavailability, Efficacy and Safety of Epanova® and Lovaza® in Men and Women With a History of Pancreatitis
A Randomized, Open-Label Crossover Study to Compare the Relative Bioavailability, Efficacy, and Safety of Epanova® and Lovaza® in Men and Women With a History of Pancreatitis
Status: Enrolling
Updated: 7/29/2015
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
An Open-Label Crossover Study to Compare the Relative Bioavailability, Efficacy and Safety of Epanova® and Lovaza® in Men and Women With a History of Pancreatitis
A Randomized, Open-Label Crossover Study to Compare the Relative Bioavailability, Efficacy, and Safety of Epanova® and Lovaza® in Men and Women With a History of Pancreatitis
Status: Enrolling
Updated:  7/29/2015
Clinical Research Facility
mi
from
Philadelphia, PA
An Open-Label Crossover Study to Compare the Relative Bioavailability, Efficacy and Safety of Epanova® and Lovaza® in Men and Women With a History of Pancreatitis
A Randomized, Open-Label Crossover Study to Compare the Relative Bioavailability, Efficacy, and Safety of Epanova® and Lovaza® in Men and Women With a History of Pancreatitis
Status: Enrolling
Updated: 7/29/2015
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
An Open-Label Crossover Study to Compare the Relative Bioavailability, Efficacy and Safety of Epanova® and Lovaza® in Men and Women With a History of Pancreatitis
A Randomized, Open-Label Crossover Study to Compare the Relative Bioavailability, Efficacy, and Safety of Epanova® and Lovaza® in Men and Women With a History of Pancreatitis
Status: Enrolling
Updated:  7/29/2015
Research Site
mi
from
Chocoutimi,
An Open-Label Crossover Study to Compare the Relative Bioavailability, Efficacy and Safety of Epanova® and Lovaza® in Men and Women With a History of Pancreatitis
A Randomized, Open-Label Crossover Study to Compare the Relative Bioavailability, Efficacy, and Safety of Epanova® and Lovaza® in Men and Women With a History of Pancreatitis
Status: Enrolling
Updated: 7/29/2015
Research Site
mi
from
Chocoutimi,
Click here to add this to my saved trials
Treatment of Muscle Cramps in Patients With Liver Cirrhosis
A Pilot Study of Hydroxychloroquine for the Treatment of Muscle Cramps in Patients With Cirrhosis
Status: Enrolling
Updated:  7/29/2015
The Mayo Clinic
mi
from
Rochester, MN
Treatment of Muscle Cramps in Patients With Liver Cirrhosis
A Pilot Study of Hydroxychloroquine for the Treatment of Muscle Cramps in Patients With Cirrhosis
Status: Enrolling
Updated: 7/29/2015
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Registry for Eosinophilic Gastrointestinal Disorders (REGID)
Registry for Eosinophilic Gastrointestinal Disorders (REGID)
Status: Enrolling
Updated:  7/30/2015
Rady Children's Hospital
mi
from
San Diego, CA
Registry for Eosinophilic Gastrointestinal Disorders (REGID)
Registry for Eosinophilic Gastrointestinal Disorders (REGID)
Status: Enrolling
Updated: 7/30/2015
Rady Children's Hospital
mi
from
San Diego, CA
Click here to add this to my saved trials
Registry for Eosinophilic Gastrointestinal Disorders (REGID)
Registry for Eosinophilic Gastrointestinal Disorders (REGID)
Status: Enrolling
Updated:  7/30/2015
Children'S Hospital
mi
from
Aurora, CO
Registry for Eosinophilic Gastrointestinal Disorders (REGID)
Registry for Eosinophilic Gastrointestinal Disorders (REGID)
Status: Enrolling
Updated: 7/30/2015
Children'S Hospital
mi
from
Aurora, CO
Click here to add this to my saved trials
Registry for Eosinophilic Gastrointestinal Disorders (REGID)
Registry for Eosinophilic Gastrointestinal Disorders (REGID)
Status: Enrolling
Updated:  7/30/2015
Northwestern University School of Medicine
mi
from
Chicago, IL
Registry for Eosinophilic Gastrointestinal Disorders (REGID)
Registry for Eosinophilic Gastrointestinal Disorders (REGID)
Status: Enrolling
Updated: 7/30/2015
Northwestern University School of Medicine
mi
from
Chicago, IL
Click here to add this to my saved trials
Registry for Eosinophilic Gastrointestinal Disorders (REGID)
Registry for Eosinophilic Gastrointestinal Disorders (REGID)
Status: Enrolling
Updated:  7/30/2015
Riley Children's Hospital
mi
from
Indianapolis, IN
Registry for Eosinophilic Gastrointestinal Disorders (REGID)
Registry for Eosinophilic Gastrointestinal Disorders (REGID)
Status: Enrolling
Updated: 7/30/2015
Riley Children's Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials